⌘K

Login Start Free

Home/Filings/4/0001250853-14-000025

4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001250853-14-000025

$SLSCIK 0001390478operating

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 8:55 PM ET

Size

11.8 KB

Accession

0001250853-14-000025

Insider Transaction Report

Form 4

Period: 2014-01-15

Galena Biopharma, Inc.GALE

Director

Transactions

Exercise/Conversion
Common Stock
2014-01-15$1.18/sh+100,000$118,000→ 103,500 total
Exercise/Conversion
Common Stock
2014-01-15$0.85/sh+100,000$85,000→ 203,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-15−100,000→ 0 total
Exercise: $1.18From: 2011-03-25Exp: 2021-03-24→ Common Stock (0 underlying)
Sale
Common Stock
2014-01-17$6.90/sh−200,000$1,380,000→ 3,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-15−100,000→ 0 total
Exercise: $0.85From: 2011-09-27Exp: 2021-09-27→ Common Stock (0 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001390478

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 8:55 PM ET
Size: 11.8 KB

View on SEC.gov